Please login to the form below

Not currently logged in
Email:
Password:

medical device

This page shows the latest medical device news and features for those working in and with pharma, biotech and healthcare.

Innovation in the time of coronavirus

Innovation in the time of coronavirus

The Distancer is a simple, handheld device that aims to help ensure the safety of key workers. ... medical device manufacturers and medical training centres.

Latest news

  • Key emerging trends in digital health Key emerging trends in digital health

    An exciting development for those living with type 1 diabetes comes from Abbott, a glucose sensing technology company, and Insulet, a diabetes medical device company, who have partnered to develop integrated ... The results showed that medical students

  • It’s Brexit day – now comes the really hard stuff It’s Brexit day – now comes the really hard stuff

    It wants “the closest alignment possible” between the UK and EU on medicine and medical device regulations, and for the Medicines and Healthcare products Regulatory Agency (MHRA) to remain part of ... Meanwhile, a European Parliament committee called

  • The digital shift in pharma marketing The digital shift in pharma marketing

    This was primarily because HCPs across the globe were already using smartphones as the most preferred device for accessing medical information. ... Technology advances changed the role of medical representatives and they became seen as conduits for

  • Pharma’s race to digital Pharma’s race to digital

    As medicine or medical device companion DTX becomes the norm, the treatment development process will need to be redesigned to align the slow medicine lifecycle with faster digital technology development and ... There should be a willingness also to see

  • The Unhappiness Project The Unhappiness Project

    And manufacturers – both medical device and pharmaceutical – are no less miserable as they face a barrage of questions from lawmakers about their costs and pricing practices, and a slew of disapproving

More from news
Approximately 0 fully matching, plus 203 partially matching documents found.

Latest Intelligence

  • The far-reaching impact of the COVID-19 pandemic on clinical trials The far-reaching impact of the COVID-19 pandemic on clinical trials

    At every time point, clinical trials will continue to be the engine room that propels medical innovation forward. ... They explore the implications of the pandemic on clinical trials for the pharmaceutical and medical device industries on their Ripple

  • Emerging use cases of blockchain in healthcare and the life sciences

    Clinical trials management. Clinical trials are highly complex endeavours, with a range of stakeholders including patients or study subjects, study sponsors, drug and medical device providers, clinical investigators, healthcare professionals and

  • Bringing the trial to the patient Bringing the trial to the patient

    The study further found that the location of the medical centre was ranked highly as a least-liked aspect of the clinical study experience, second only to the possibility of receiving ... In fact, according to the 2nd Annual Patient- Centric Benchmark

  • Assessing the value of interim analyses in clinical trials Assessing the value of interim analyses in clinical trials

    There may. be a single analysis or more at different points of time depending on the number of subjects and the drug or device being tested. ... How to decide which methodology to use is not an easy choice for pharma or medical device companies.

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    year. Botox is facing tougher competition in the market from new migraine drugs as well as rivals in its medical aesthetics indications. ... risperidone), as well as hip replacement and vaginal mesh products in its medical device business.

More from intelligence
Approximately 0 fully matching, plus 45 partially matching documents found.

Latest appointments

  • Ex-J&J exec Denice Torres joins bluebird bio’s board Ex-J&J exec Denice Torres joins bluebird bio’s board

    She also served as chief strategy and transformation officer for J&J’s medical device division. ... bluebird. “Denice brings valuable perspective and exceptional industry insights based on over 25 years of executive management experience in

  • Christie Anbar appointed global healthcare lead at Ruder Finn Christie Anbar appointed global healthcare lead at Ruder Finn

    In those roles, she led award-winning work for a range of client from pre-IPO startups to emerging biotech, large pharma and medical device companies, as well as patient and

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    Starting off in Abbott’s Diabetes Care business, Ford has since served in many leadership roles within the company, including in the Nutrition and Medical Device businesses. ... He worked as executive vice president of Medical Devices, in which he

  • New faces at Lucid, 90Ten and Page & Page New faces at Lucid, 90Ten and Page & Page

    She was most recently at Cello Health Communications, bringing seven years of experience in medical education. ... Bates has 17 years’ experience developing content for pharmaceutical and medical device industries.

  • Dr Martin Rothman joins Sofinnova Partners Dr Martin Rothman joins Sofinnova Partners

    Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... There, he will focus on helping the team identify and evaluate “promising” medical device companies.

More from appointments
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 113 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics